Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jupiter Neurosciences (JUNS) Cash & Current Investments (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed Cash & Current Investments for 2 consecutive years, with $3.8 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 0.53% to $3.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Dec 2025, up 0.53% year-over-year, with the annual reading at $3.8 million for FY2025, 0.53% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $3.8 million at Jupiter Neurosciences, up from $723797.0 in the prior quarter.
  • The five-year high for Cash & Current Investments was $3.8 million in Q4 2025, with the low at $253.0 in Q3 2024.